Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. LMT
9. SPY
10. SBUX

Go back to Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results

Vanda Pharmaceuticals (VNDA) Reports Q2 Loss Per Share of 1c, Offers Guidance

July 29, 2015 4:35 PM EDT

Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q2 EPS of ($0.01), $0.28 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $27.6 million versus the consensus estimate of $24.55 million.

2015... More